- 5 Risultati
prezzo più basso: € 65,99, prezzo più alto: € 171,03, prezzo medio: € 131,30
1
Ordina
da AbeBooks.de
€ 85,97
Spedizione: € 0,001
OrdinaLink sponsorizzato
Giordano, Antonio / Normanno, Nicola:

Breast Cancer in the Post-Genomic Era - nuovo libro

ISBN: 1607614669

[EAN: 9781607614661], Neubuch, Publisher/Verlag: Springer, Berlin | Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakth… Altro …

  - NEW BOOK Costi di spedizione:Versandkostenfrei (EUR 0.00) English-Book-Service - A Fine Choice, Waldshut-Tiengen, Germany [1048135] [Rating: 4 (von 5)]
2
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Ordina
da Orellfuessli.ch
CHF 183,00
(indicativi € 163,61)
Spedizione: € 16,091
OrdinaLink sponsorizzato

Nicola Normanno#Antonio Giordano:

Breast Cancer in the Post-Genomic Era - nuovo libro

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Altro …

No. 17938214. Costi di spedizione:Zzgl. Versandkosten. (EUR 16.09)
3
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Ordina
da Thalia.de
€ 65,99
Spedizione: € 0,001
OrdinaLink sponsorizzato
Nicola Normanno#Antonio Giordano:
Breast Cancer in the Post-Genomic Era - nuovo libro

ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Altro …

  - No. 17938214. Costi di spedizione:, Lieferbar in 2 - 3 Wochen, DE. (EUR 0.00)
4
Breast Cancer in the Post-Genomic Era - Nicola Normanno#Antonio Giordano
Ordina
da Orellfuessli.ch
CHF 183,00
(indicativi € 169,92)
Spedizione: € 16,711
OrdinaLink sponsorizzato
Nicola Normanno#Antonio Giordano:
Breast Cancer in the Post-Genomic Era - edizione con copertina flessibile

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Altro …

Nr. 17938214. Costi di spedizione:, wird besorgt, Lieferzeit unbekannt, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.71)
5
Breast Cancer in the Post-Genomic Era
Ordina
da Orellfuessli.ch
CHF 183,00
(indicativi € 171,03)
OrdinaLink sponsorizzato
Breast Cancer in the Post-Genomic Era - edizione con copertina flessibile

2013, ISBN: 9781607614661

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… Altro …

Nr. 17938214. Costi di spedizione:Does not ship to your country., Costi di spedizione aggiuntivi

1Poiché alcune piattaforme non trasmettono le condizioni di spedizione e queste possono dipendere dal paese di consegna, dal prezzo di acquisto, dal peso e dalle dimensioni dell'articolo, dall'eventuale iscrizione alla piattaforma, dalla consegna diretta da parte della piattaforma o tramite un fornitore terzo (Marketplace), ecc. è possibile che le spese di spedizione indicate da eurolibro non corrispondano a quelle della piattaforma offerente.

Dati bibliografici del miglior libro corrispondente

Dettagli del libro
Breast Cancer in the Post-Genomic Era

Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma. The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.

Informazioni dettagliate del libro - Breast Cancer in the Post-Genomic Era


EAN (ISBN-13): 9781607614661
ISBN (ISBN-10): 1607614669
Copertina rigida
Copertina flessibile
Anno di pubblicazione: 201307
Editore: Springer
230 Pagine
Lingua: Englisch

Libro nella banca dati dal 2009-10-31T19:21:07+01:00 (Zurich)
Pagina di dettaglio ultima modifica in 2021-06-05T21:18:20+02:00 (Zurich)
ISBN/EAN: 9781607614661

ISBN - Stili di scrittura alternativi:
1-60761-466-9, 978-1-60761-466-1
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : giordano
Titolo del libro: cancer the breast, post


Dati dell'editore

Autore: Antonio Giordano; Nicola Normanno
Titolo: Current Clinical Oncology; Breast Cancer in the Post-Genomic Era
Editore: Humana Press
230 Pagine
Anno di pubblicazione: 2013-09-01
Stampato / Fatto in
Lingua: Inglese
79,29 € (DE)
81,51 € (AT)
115,00 CHF (CH)
Available

BC; PB; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Mammory Glands; Breast Cancer; Gene Expression; TGF-B Signaling; Breast Cancer therapy; Genomic Basis; Professional/practitioner; BB

Potential Contributors and Temptative Titles Section I: The biology of the mammary gland: Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA Title: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, Maryland Title: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancer Barbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA Title: The genetic of breast cancer: application in clinical practice Ashok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.K Title: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancer Nancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231 Title: DNA methylation in breast cancer Antonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA Title: Alterations of cell cycle regulatory genes in breast cancer David S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892 Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasia William J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJ Title: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatment William J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1 Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancer Eric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USA Title: Gene expression profiling in breast cancer: clinical applications Emanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110 Title: Proteomics in breast cancer Section V: Novel therapeutic approaches Erik P. Winer, Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. Title: The endocrine therapy of breast cancer in the era of the aromatase inhibitors Nicola Normanno, Cell Biology and Preclinical Models Unit, INT-Fondazione Pascale, Naples, Italy Title: Signal transduction inhibitors for treatment and prevention of breast cancer Jose Baselga, Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain. Title: Monoclonal antibodies in breast cancer therapy: current status and future development Carlos L. Arteaga, Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232 USA Title: TGFbeta antagonists: a novel approach fro treatment of breast cancer? Francesco Perrone, Clinical Trials Unit, INT-Fondazione Pascale, Naples, Italy Integration of target based agents in current protocols of breast cancer therapy

Altri libri che potrebbero essere simili a questo:

Ultimo libro simile:
9781603279451 Breast Cancer in the Post-Genomic Era (Springer)


< Per archiviare...